We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Products » Brexit and Life Sciences Companies - Webinar CD/Transcript

Other Options

Audio CD/Transcript - May 31, 2017

$287.00

Audio CD/Transcript - May 31, 2017

$258.00

Audio CD/Transcript - May 31, 2017

$244.00

Audio CD/Transcript - May 31, 2017

$230.00

Audio CD/Transcript - May 31, 2017

$215.00

Brexit and Life Sciences Companies - Webinar CD/Transcript

$287.00
Device Products

Product Details

Brexit and Life Sciences Companies

Your international drug and device business is at a crossroads known as ‘Brexit’ — the imminent departure of the United Kingdom (U.K.) from the European Union (EU).

Terms of departure are to be negotiated over the coming two years. What will the final outcome look like? Will there be a deal for duty-free movement of goods among nations? Or will punitive tariffs ensue? These are just a few of the questions to which you need answers — ASAP.

FDAnews has invited global drug-and-device expert Michael Burke Esq. to share his crystal ball. As law his firm’s in-house expert on drugs and devices as well as a specialist in cross-border international trade, Mr. Burke is uniquely qualified.

Get set for an information-fest. In 90 fast-paced minutes, Mr. Burke will cover the make-or-break questions, including:

  • How might Brexit affect my operation, both short- and long-term?
  • Should I consider moving operations into or out of the U.K?
  • What are the advantages and disadvantages of operating in Ireland?
  • With the European Medicines Agency (EMA) moving out of the UK, how will marketing authorization in both the EU and U.K. be affected?

Order NOW

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing